GameStop Corp. (GME) was up +18.12% to $76.79. After having more than doubled at the beginning of the day, GameStop won another 18 percent. On Friday, the stock of the video game store had already risen 51 percent, sparking a tug-of-war between the Bearish analytics company Citron Analysis and “day traders” mobilized in favor of Gamestop on the social network Reddit. The “day traders” prevailed, pressuring short sellers to redeem themselves on this stock in a panic that now looks quite overvalued at the fundamental level. In this way, the analyst Telsey lowered the recommendation from ‘Outperform’ to ‘Underperform’.

Kimberly-Clark Corporation (KMB) was up +3.25% to $136.51. The U.S. consumer goods provider posted revenue of $4.8 billion in the fourth quarter of 2020, up 6 percent, with organic growth of 5 percent. The net diluted quarterly EPS was $1.58, nearly constant. The adjusted quarterly EPS was $1.69, compared with $1.71 a year ago. The consensus was $1.6 adjusted EPS with sales of $4.71 billion. Revenues are forecast to rise by 4 to 6 percent for the 2021 financial year. It is estimated that adjusted earnings per share will be between $7.75 and $8. For the year ahead, the consensus was $7.77 adjusted EPS for sales of $19.54 billion.

Electronic Arts Inc. (EA) was stable at +0.21% to $146.3 while Take-Two Interactive Software, Inc. (TTWO) was also stable but -0.33% to $203.99. Goldman Sachs has only reinstated its “Buy” recommendation on the stocks of the two publishers of video games. On the other hand, in the health situation that we know, GS downgraded IMAX Corporation (IMAX) from “Buy” to “Neutral.” IMAX was up +1.41% to $18.73 in Monday session.

The Blackstone Group Inc. (BX) remained stable by -0.08% to $64.98. The purchase of Foley Trasimene, the company of founder Bill Foley, is reportedly close to the case of Reuters closing the acquisition of Blackstone’s Alight Solution business services division on the grounds of a $7.3 billion valuation, including debt.

LEAVE A REPLY

Please enter your comment!
Please enter your name here